Pharvaris Information Ratio
| PHVS Stock | | | USD 30.09 0.41 1.38% |
The Information Ratio measures excess return (alpha) per unit of tracking error relative to a benchmark. Unlike the Sharpe Ratio, which uses total volatility, the Information Ratio isolates only the variability of the alpha component — the return attributable to active decisions rather than passive market exposure. Below is Pharvaris's current Information Ratio with peer comparisons and related risk metrics.
Current Information Ratio Value
Pharvaris registers a Information Ratio of 0.0832, reflecting positive but modest excess return per unit of tracking risk. Pharvaris has outperformed its benchmark, though the margin is limited relative to the tracking error incurred.
INFOR | = | ER[a] - ER[b]STD[a] |
| = | 0.0832 | |
Information Ratio Peers Comparison
Pharvaris's Information Ratio of 0.0832 falls above the 0.01 peer average. Values range from -0.1568 (Upstream Bio) to 0.2968 (Spyre Therapeutics), with wide dispersion across the group. Pharvaris's risk-adjusted return exceeds the peer average, indicating more efficient compensation for risk taken.
Information Ratio Relative To Other Indicators
The chart below plots Information Ratio against Maximum Drawdown for Pharvaris and its peers. Each point represents one equity — position along the horizontal axis shows Information Ratio while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Information Ratio (
0.08 ) to Maximum Drawdown (
15.10 ) for Pharvaris yields a
181.52 multiple. This indicates Maximum Drawdown substantially exceeds Information Ratio for Pharvaris.
Compare Pharvaris to PeersMethodology, Assumptions & Data Sources
Pharvaris' Information Ratio currently stands at 0.0832. This Information Ratio reading for Pharvaris results from applying the indicator's calculation rules to price and volume data over the selected window. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Pharvaris operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators